HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunisation against ovine caseous lymphadenitis: efficacy of monocomponent Corynebacterium pseudotuberculosis toxoid vaccine and combined clostridial-corynebacterial vaccines.

Abstract
Sheep were immunised with Corynebacterium pseudotuberculosis toxoid formulated as a monocomponent vaccine with aluminium adjuvant or in combination with 5 clostridial antigens, and also in the combined form with sodium selenate. Immunised and control sheep were experimentally infected 16 days after vaccination and slaughtered and inspected after a further 3 months to determine their resistance to infection. All 3 vaccines afforded an equal and high level of protection; 91% of vaccinated sheep exhibiting no lesions of caseous lymphadenitis compared with 51.5% affected sheep in the control group. Average lesion counts were 1.2 per affected vaccinated sheep and 4.5 per affected control sheep. Antitoxin responses to the clostridial toxoids incorporated in the combined vaccines were not affected by inclusion of the C pseudotuberculosis toxoid or the sodium selenate.
AuthorsD G Eggleton, C V Doidge, H D Middleton, D W Minty
JournalAustralian veterinary journal (Aust Vet J) Vol. 68 Issue 10 Pg. 320-1 (Oct 1991) ISSN: 0005-0423 [Print] England
PMID1755782 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Bacterial
  • Bacterial Vaccines
  • Toxoids
Topics
  • Animals
  • Antibodies, Bacterial (biosynthesis)
  • Bacterial Vaccines
  • Clostridium (immunology)
  • Corynebacterium Infections (prevention & control, veterinary)
  • Corynebacterium pseudotuberculosis (immunology)
  • Lymphadenitis (prevention & control, veterinary)
  • Male
  • Sheep
  • Sheep Diseases (prevention & control)
  • Toxoids (immunology)
  • Vaccination (veterinary)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: